In line with these studies, it has recently been reported that OSM may play a stimulatory role in bone metastases of ER+ (estrogen receptor positive) breast cancer cells in which the OSMR is more highly expressed compared to the less aggressive ER− cells [145]. The gene discussed is ESR1; the disease is breast carcinoma.